Downregulation of TAB182 Promotes Cancer Stem-Like Cell Properties and Therapeutic Resistance in Triple-Negative Breast Cancer Cells

The authors revealed a novel function of TAB182 as a potential negative regulator of cancer stem-like properties and drug sensitivity in triple-negative breast cancer cells.
[BMC Cancer]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News